Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 908350-80-1 | MDL No. : | MFCD11973624 |
Formula : | C17H20BNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CMGIUUPUDMXXLT-UHFFFAOYSA-N |
M.W : | 281.16 | Pubchem ID : | 53482118 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.35 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 86.15 |
TPSA : | 31.35 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.53 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.5 |
Log Po/w (WLOGP) : | 3.05 |
Log Po/w (MLOGP) : | 1.89 |
Log Po/w (SILICOS-IT) : | 2.9 |
Consensus Log Po/w : | 2.27 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.08 |
Solubility : | 0.0234 mg/ml ; 0.0000834 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.84 |
Solubility : | 0.0405 mg/ml ; 0.000144 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -6.14 |
Solubility : | 0.000205 mg/ml ; 0.000000728 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.02 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | Stage #1: With n-butyllithium In tetrahydrofuran at -78℃; for 1 h; |
To a solution of 2-(4'-bromophenyl)pyridine (0.468 g, 2 mmol). in anhydrous THF (10 ml) was added dropwse n-BuL (3 ml, 3.6 mmol) at -78"C The reaction was stirred 1 h, then 2-isopropoxy-4,4,5>5-tetramethyl-l,3,2-dioxaborolane (0.52 ml, 2.5 mmol) was added. The mixture was stirred overnight. Then Hie reaction was quenched with water and extracted with dchloromethane (30 ml) 3 times. The organic layer was -washed with brine and dried over MgSO4 and concentrated in vacuo. After column chromatography (silica gel, ethyl acetate: hexane = 1: 20) to give product 0.22 g (39percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With potassium acetate; tricyclohexylphosphine In 1,4-dioxane for 20 h; Inert atmosphere; Reflux | 1. Preparation of 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)pyridine 0.39 g (0.4 mmol) of Pd(dba)3 and 0.28 g (1 mmol) of tricyclohexylphosphine are suspended in 10 ml of dry dioxane under a nitrogen atmosphere. The resulting mixture is stirred at room temperature for 30 minutes. Subsequently, 5.3 g (15 mmol) of bis(pinacolato)diboron, 2.1 g (21 mmol) of KOAc and 3.3 g (14 mmol) of 2-(4-bromophenyl)pyridine are added gradually. The reaction mixture is boiled under reflux for 20 hours, cooled and treated with 10 ml of water at room temperature. The product is extracted with dichloromethane. The solvent is removed under reduced pressure and the resulting crude product is purified by means of a short silica gel column. After purification by means of the silica gel column (dichloromethane/hexane, 3:1), 82percent of the desired product is obtained. 1H NMR(CDCl3): δ=1.37(s,12H), 7.22-7.26(m, 1H), 7.72-7.80(m, 2H), 7.92(J=8.4 Hz, 2H), 8.02(J=8.2Hz, 2H), 8.71(J=4.9 Hz, 1H). |
11.2 g | for 2 h; Inert atmosphere; Reflux | First, a solution was added cyclopentyl methyl ether (CPME) in (64 ml) 2-(4- bromophenyl) pyridine (15 g) and bis (pinacolato) diboron (19.5 g), under a nitrogen atmosphere, palladium acetate (Pd ( OAc) 2) (0.4g), triphenylphosphine (PPh3) (1.5g) and potassium acetate (AcOK) (18.9g) was added with stirring at room temperature. After stirring for 2 hours at reflux temperature, the reaction mixture was cooled to room temperature, was added with ethylenediaminetetraacetic acid (EDTA) solution (35 ml) in toluene (500ml). The organic matter to remove salts by water washing operation was purified with activated carbon column chromatography (toluene). There was thus obtained 2- (4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) pyridine (11.2 g). |
[ 929203-04-3 ]
3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
Similarity: 0.96
[ 879291-27-7 ]
2-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.93
[ 1009033-87-7 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
Similarity: 0.91
[ 1313519-78-6 ]
2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.87
[ 893567-09-4 ]
2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.86
[ 929203-04-3 ]
3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
Similarity: 0.96
[ 879291-27-7 ]
2-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.93
[ 1009033-87-7 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
Similarity: 0.91
[ 1313519-78-6 ]
2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.87
[ 867164-54-3 ]
2-Phenyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline
Similarity: 0.84
[ 929203-04-3 ]
3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
Similarity: 0.96
[ 879291-27-7 ]
2-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.93
[ 1009033-87-7 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine
Similarity: 0.91
[ 1313519-78-6 ]
2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.87
[ 893567-09-4 ]
2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Similarity: 0.86